Immunome (IMNM) Stock Highlights

12.28 | +1.57%

2024-10-21 03:14:33

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The companys primary focus areas are oncology and infectious disease, including COVID-19. It primarily operates in the U.S.

Statistics

Range Today

12.08 12.46

Volume Today 396K

Range 1 Year

6.93 30.96

Volume 1 Year 164.37M

Range 3 Year

2.09 30.96

Volume 3 Year 205.76M

Range 10 Year

2.09 63.78

Volume 10 Year 265.28M

Highlights

Market Capitalization 737.47M (small)

Floating Shares 43.14M

Current Price 12.28

Price To Earnings -1.62

Price To Revenue 42.83

Price To Book 2.9

Earnings Per Share -7.54

Payout Ratio 0%

Performance

Latest +1.57%

1 Month -20.36%

3 Months -12.47%

6 Months -29.18%

1 Year +39.86%

3 Years -29.02%

5 Years -21.58%

10 Years -21.58%

Benchmarks

Market Capitalization

0 / 368

Gross Profits

0 / 278

Total Revenue

0 / 300

Total Rank

0 / 368

Free Cashflow

0 / 352

Performance 5 years

0 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.